Incidence of selected adverse events in a population-based Danish cohort with atopic dermatitis treated with conventional systemic therapies: a matched case-cohort study.

Study identification

• EU PAS number:
  EUPAS1000000628
• Study ID:
  1000000628
• Official title and acronym:
  Incidence of selected adverse events in a population-based Danish cohort with atopic dermatitis treated with conventional systemic therapies: a matched case-cohort study.
• DARWIN EU® study:
  No
• Study countries:
  Denmark
• Study description:
  To investigate adverse events of special interest in a dermatologist-verified adult patient population with atopic dermatitis (AD) receiving conventional systemic therapies.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Pfizer

Study timelines

Date when funding contract was signed

Planned:20/02/2025

Actual:20/02/2025

Study start date

Planned:07/11/2025

Actual:07/11/2025

Date of final study report

Planned:23/11/2026

Sources of funding

More details on funding

No information provided.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable